CA2486345A1 - Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira - Google Patents

Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira Download PDF

Info

Publication number
CA2486345A1
CA2486345A1 CA002486345A CA2486345A CA2486345A1 CA 2486345 A1 CA2486345 A1 CA 2486345A1 CA 002486345 A CA002486345 A CA 002486345A CA 2486345 A CA2486345 A CA 2486345A CA 2486345 A1 CA2486345 A1 CA 2486345A1
Authority
CA
Canada
Prior art keywords
functionally equivalent
equivalent sequences
polypeptides
seq
bigl1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002486345A
Other languages
English (en)
Other versions
CA2486345C (fr
Inventor
Albert I. Ko
Mitermayer Galvao Reis
Julio Henrique Rosa Croda
Isadora Cristina Siqueira
David A. Haake
James Matsunaga
Lee W. Riley
Michele Barocchi
Tracy Ann Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
University of California
Cornell Research Foundation Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/147,299 external-priority patent/US20040058323A1/en
Application filed by Individual filed Critical Individual
Publication of CA2486345A1 publication Critical patent/CA2486345A1/fr
Application granted granted Critical
Publication of CA2486345C publication Critical patent/CA2486345C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)

Abstract

L'invention porte sur trois molécules d'ADN isolées qui codent pour les protéines BigL1, BigL2 et BigL3 dans la bactérie Leptospira, ces protéines ayant des domaines de répétition de bactérie, type Ig, et sur leur utilisation dans des applications diagnostiques, thérapeutiques et de vaccination. Selon cette invention, les molécules isolées codant pour les protéines BigL1, BigL2 et BigL3 sont utilisées dans le diagnostic et la prévention d'infection par l'espèce Leptospira qui est capable de générer des maladies chez l'homme et autres mammifères, y compris celles à caractère vétérinaire.
CA2486345A 2002-05-17 2002-05-20 Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira Expired - Fee Related CA2486345C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/147,299 US20040058323A1 (en) 2002-05-17 2002-05-17 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species
US10/147,299 2002-05-17
PCT/BR2002/000072 WO2003098214A1 (fr) 2002-05-17 2002-05-20 Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira

Publications (2)

Publication Number Publication Date
CA2486345A1 true CA2486345A1 (fr) 2003-11-27
CA2486345C CA2486345C (fr) 2012-08-14

Family

ID=34195214

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2486345A Expired - Fee Related CA2486345C (fr) 2002-05-17 2002-05-20 Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira

Country Status (5)

Country Link
EP (1) EP1514104B1 (fr)
AU (1) AU2002308453B2 (fr)
CA (1) CA2486345C (fr)
DE (1) DE60222812T2 (fr)
WO (1) WO2003098214A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2501939C (fr) 2002-10-10 2013-10-08 Cornell Research Foundation, Inc. Nouvelles proteines immunogenes de leptospira
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
BRPI0505529A (pt) 2005-12-19 2007-09-25 Fundacao Oswaldo Cruz proteìnas liga e ligb (leptospiral ig-like(lig) domains) para vacinação e diagnóstico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091301A (en) * 1989-03-22 1992-02-25 The Unites States Of America As Represented By The Secretary Of Agriculture Diagnostic and epidemiological nucleic acid probe for bovine leptospirosis
IL121820A0 (en) * 1996-01-22 1998-02-22 Univ California Leptospiral outer membrane proteins

Also Published As

Publication number Publication date
EP1514104A1 (fr) 2005-03-16
DE60222812T2 (de) 2008-08-28
AU2002308453B2 (en) 2009-12-03
WO2003098214A1 (fr) 2003-11-27
DE60222812D1 (de) 2007-11-15
EP1514104A4 (fr) 2005-12-07
EP1514104B1 (fr) 2007-10-03
CA2486345C (fr) 2012-08-14
AU2002308453A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
Tung et al. A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family
US7582304B2 (en) Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans
ES2378051T3 (es) Compuestos y métodos para el diagnóstico de la tubercolosis.
CA2438080A1 (fr) Proteines gonococciques et acides nucleiques
US5618533A (en) Flagellin-based polypeptides for the diagnosis of lyme disease
KR20010012813A (ko) 결핵 확인용 화합물 및 이의 사용 방법
RU2006134631A (ru) Иммуногенные композиции против chlamidia pneumoniae
JP6688767B2 (ja) アナプラズマ・ファゴサイトフィルム（Ａｐｈ）およびアナプラズマ・プラチス（Ａｐｌ）に特異的な抗体を検出するための組成物および方法
WO2001079274B1 (fr) Antigenes de la tuberculose
RU97100934A (ru) Нуклеотидные последовательности пестивирусных штаммов, полипептиды, закодированные этими последовательностями, и их использование для диагностики и профилактики пестивирусных инфекций
Seong et al. Induction of neutralizing antibody in mice by immunization with recombinant 56 kDa protein of Orientia tsutsugamushi
CA2112466A1 (fr) Methodes et compositions pour le diagnostic de la maladie de lyme
Schulte-Spechtel et al. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene
JP2011518338A (ja) ボレリア・ブルグドルフェリ（ｂｏｒｒｅｌｉａｂｕｒｇｄｏｒｆｅｒｉ）の細胞エンベロープタンパク質のアレイ
Bedir et al. Simultaneous detection and differentiation of pathogenic and nonpathogenic Leptospira spp. by multiplex real-time PCR (TaqMan) assay
EP1338657A1 (fr) Séquences spécifiquement délétées du génome de Mycobacterium tuberculosis et leur utilisation dans des diagnostics et comme vaccins
Panelius et al. Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis
US10022458B2 (en) Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis
CA2486345A1 (fr) Proteines avec domaines de repetition de bacterie, type ig (big), dans l'espece leptospira
Coyle Borrelia burgdorferi infection: clinical diagnostic techniques
US5283175A (en) Genus-specific oligomers of Borrelia and methods of using same
EP1054895B1 (fr) Reactif de diagnostic, peptide et trousse de detection de la rickettsiose
Lin et al. Molecular characterization of three major outer membrane proteins, TSA56, TSA47 and TSA22, in Orientia tsutsugamushi
CN101477125B (zh) 诊断结核病的基于结核杆菌抗原性多肽的组合物
WO1992003158A1 (fr) Sequences d'acides amines et nucleotidiques de la proteine mtp40 de m. tuberculosis et peptides synthetiques derives de ces sequences

Legal Events

Date Code Title Description
EEER Examination request
FZDC Discontinued application reinstated
MKLA Lapsed

Effective date: 20200831